Annexon, Inc. (ANNX)
5.50
+0.14
(+2.61%)
USD |
NASDAQ |
Apr 02, 16:00
5.495
0.00 (0.00%)
Pre-Market: 20:00
Annexon EPS Diluted (Quarterly) : -0.2763 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pacira Biosciences, Inc. | 0.0381 |
| American Well Corp. | -1.520 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Agenus, Inc. | -0.301 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -48.26M |
| Total Expenses (Quarterly) | 48.26M |
| Enterprise Value | 670.46M |
| Earnings Yield | -24.65% |
| Normalized Earnings Yield | -24.65 |